ARTMS(tm) Products Inc. Licenses Canadian Technology to Address the Global Medical Isotope Supply Challenge

A consortium of institutions led by TRIUMF, Canada's national laboratory for particle and nuclear physics and accelerator-based science, is granting sole rights for its proprietary technetium-99m (Tc-99m) production technology to ARTMS(tm) Products, Inc (ARTMS). Technetium-99m is used in over 80% of all nuclear medicine imaging procedures and is vital to patient care in areas such as cardiology, oncology, and neurology.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews